David Cox, M.D., Ph.D.

Co-founder and Chief Scientific Officer of Perlegen Sciences, Inc.
 
Dr. David Cox, recognized internationally for his research on the molecular basis of human genetic disease, is co-founder and chief scientific officer of Perlegen Sciences, Inc. Perlegen, with headquarters in Mountain View, Calif., facilitates development of genetically-targeted, late-stage therapeutics and diagnostics, and works toward uncovering the genetic causes of diseases.
 
Dr. Cox has been chief scientific officer of Perlegen since its formation in 2000. He was professor of genetics and pediatrics at the Stanford University School of Medicine, as well as the co-director of the Stanford Genome Center. He obtained his A.B. and M.S. degrees from Brown University, R.I., and his M.D. and Ph.D. degrees from the University of Washington, Seattle. He completed a pediatric residency at the Yale-New Haven Hospital in New Haven, Conn., and was a fellow in both genetics and pediatrics at the University of California, San Francisco. Dr. Cox is certified by the American Board of Pediatrics and the American Board of Medical Genetics. He was an integral participant in the large-scale mapping and sequencing efforts of the Human Genome Project while carrying out research involving the molecular basis of human genetic disease.
 
He has served on several international and national councils and commissions including the Council of the Human Genome Organization (HUGO) and the National Bioethics Advisory Commission (NBAC).
 
Dr. Cox's honors include election to the Institute of Medicine of the National Academy of Sciences. He has authored over 100 peer-reviewed scientific publications and has served on numerous editorial boards.